These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 20080770)

  • 21. In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses.
    Checkmahomed L; Padey B; Pizzorno A; Terrier O; Rosa-Calatrava M; Abed Y; Baz M; Boivin G
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33049959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Favipiravir, a new concept of antiviral drug against influenza viruses].
    Reina J; Reina N
    Rev Esp Quimioter; 2017 Apr; 30(2):79-83. PubMed ID: 28176519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice.
    Ilyushina NA; Hay A; Yilmaz N; Boon AC; Webster RG; Govorkova EA
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3889-97. PubMed ID: 18725448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells.
    Smee DF; Hurst BL; Egawa H; Takahashi K; Kadota T; Furuta Y
    J Antimicrob Chemother; 2009 Oct; 64(4):741-6. PubMed ID: 19643775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of novel reassortant avian influenza H7N9 virus infection in vitro with three antiviral drugs, oseltamivir, peramivir and favipiravir.
    Cao RY; Xiao JH; Cao B; Li S; Kumaki Y; Zhong W
    Antivir Chem Chemother; 2014 Dec; 23(6):237-40. PubMed ID: 23948557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the susceptibility of highly pathogenic avian influenza H5N1 viruses to oseltamivir using embryonated chicken eggs.
    Tare DS; Kode SS; Hurt AC; Pawar SD
    Indian J Med Res; 2019 Nov; 150(5):486-491. PubMed ID: 31939392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza virus resistance to antiviral agents: a plea for rational use.
    Poland GA; Jacobson RM; Ovsyannikova IG
    Clin Infect Dis; 2009 May; 48(9):1254-6. PubMed ID: 19323631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
    Hurt AC; Selleck P; Komadina N; Shaw R; Brown L; Barr IG
    Antiviral Res; 2007 Mar; 73(3):228-31. PubMed ID: 17112602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.
    McKimm-Breschkin JL; Barrett S; Wong FYK; Pudjiatmoko ; Azhar M; Selleck P; Davies KR; Hartaningsih N; McGrane J
    Antiviral Res; 2018 May; 153():95-100. PubMed ID: 29574145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.
    Triana-Baltzer GB; Gubareva LV; Nicholls JM; Pearce MB; Mishin VP; Belser JA; Chen LM; Chan RW; Chan MC; Hedlund M; Larson JL; Moss RB; Katz JM; Tumpey TM; Fang F
    PLoS One; 2009 Nov; 4(11):e7788. PubMed ID: 19893747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in Mice.
    Marathe BM; Wong SS; Vogel P; Garcia-Alcalde F; Webster RG; Webby RJ; Najera I; Govorkova EA
    Sci Rep; 2016 May; 6():26742. PubMed ID: 27221530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of favipiravir (T-705) against wild-type and oseltamivir-resistant influenza B virus in mice.
    Fang QQ; Huang WJ; Li XY; Cheng YH; Tan MJ; Liu J; Wei HJ; Meng Y; Wang DY
    Virology; 2020 Jun; 545():1-9. PubMed ID: 32174453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuraminidase inhibitors susceptibility profiles of highly pathogenic influenza A (H5N1) viruses isolated from avian species in India (2006-2015).
    Sood R; Kumar N; Bhatia S; Chanu KV; Gupta CL; Pateriya AK; Mishra A; Khandia R; Mawale N; Singh VP
    Antiviral Res; 2018 Oct; 158():143-146. PubMed ID: 30125616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
    Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus.
    Govorkova EA; Ilyushina NA; Boltz DA; Douglas A; Yilmaz N; Webster RG
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1414-24. PubMed ID: 17296744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir.
    Rameix-Welti MA; Agou F; Buchy P; Mardy S; Aubin JT; Véron M; van der Werf S; Naffakh N
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3809-15. PubMed ID: 16940075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection.
    Cho J; Yi H; Jang EY; Lee MS; Lee JY; Kang C; Lee CH; Kim K
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):298-304. PubMed ID: 29017920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt.
    Earhart KC; Elsayed NM; Saad MD; Gubareva LV; Nayel A; Deyde VM; Abdelsattar A; Abdelghani AS; Boynton BR; Mansour MM; Essmat HM; Klimov A; Shuck-Lee D; Monteville MR; Tjaden JA
    J Infect Public Health; 2009; 2(2):74-80. PubMed ID: 20701864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational studies of H5N1 influenza virus resistance to oseltamivir.
    Wang NX; Zheng JJ
    Protein Sci; 2009 Apr; 18(4):707-15. PubMed ID: 19309695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.